Possess state-of-the-Art manufacturing facilities for finished Dosage Forms & API's conforming to the most Stringent International Norms WHO-GMP, TGA (Australia), MHRA (UK). Manufacturing capacity (Finished Dosage) : 2300 million Tablets 64 million Ampoules 27 million Vials 84 million Capsules 18 million Dermatological products 62 million Oral liquid bottles Manufacturing capacity (API) : 1,50,0000 (15 lakhs) sq.
Dedicated to Gynecology, Pediatrics & GP, the division offers a wide range of medicines. These drugs are formulated at per various pharmaceutical standards and are highly effective and 100% safe. The aim of this division is to provide patients and physicians with novel improved medicines that have better efficacy and fewer side effects.